5471-59-0

Basic information

• Product Name: benzyl 1-aminocyclopentane-1-carboxylate
• Synonyms: benzyl 1-aminocyclopentane-1-carboxylate;Cyclopentanecarboxylic acid, 1-aMino-, phenylMethyl ester;benzyl 1-aminocyclopentanecarboxylate
• CAS NO: 5471-59-0
• Molecular Formula: C₁₃H₁₇NO₂
• Molecular Weight: 219.28
• Mol File: 5471-59-0.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 320.4°Cat760mmHg
• Flash Point: 172°C
• Appearance: /
• Density: 1.135g/cm³
• Vapor Pressure: 0.000318mmHg at 25°C
• Refractive Index: 1.554
• CAS DataBase Reference: benzyl 1-aminocyclopentane-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl 1-aminocyclopentane-1-carboxylate(5471-59-0)
• EPA Substance Registry System: benzyl 1-aminocyclopentane-1-carboxylate(5471-59-0)

Safety Data

• Hazardous Substances Data: 5471-59-0(Hazardous Substances Data)

Usage

InChI:InChI=1/C13H17NO2/c14-13(8-4-5-9-13)12(15)16-10-11-6-2-1-3-7-11/h1-3,6-7H,4-5,8-10,14H2

Upstream product

• 799274-04-7 (phenylmethyl) 1-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]-1-cyclopentanecarboxylate 
• 35264-09-6 1-(tert-butoxycarbonylamino)cyclopentanecarboxylic acid 
• 100-39-0 benzyl bromide 

Downstream Products

• 900522-85-2 benzyl 1-(((3R)-3-amino-1-aza-6-[(2,3-dihydro-2,2,4,6,7-pentamethyl-2H-1-benzofuran-5-yl)sulfonyl]guanidino)-2-oxohexan-1-yl)cyclopentanecarboxylate 
• 1413936-72-7 benzyl 1-(((3R)-1-aza-6-(2,3-dihydro-2,2,4,6,7-pentamethyl-2H-1-benzofuran-5-yl)sulfonylguanidino)-3-(9H-9-fluorenylmethoxycarboxamido)-2-oxohexan-1-yl)cyclopentanecarboxylate 

Relevant articles and documents

PYRIDINE COMPOUND SUBSTITUTED WITH AZOLE

The present invention provides a compound represented by formula [I] shown below or a pharmaceutically acceptable salt thereof that has an inhibitory effect on 20-HETE producing enzyme. (in formula [I] above, the structure represented by formula [II] below: represents any of the structures represented by formula group [III] below: R1, R2, R3, and R4 independently represent a hydrogen atom, a fluorine atom, methyl, or the like, R5 represents any of the structures represented by formula group [IV]:

PEPTIDIC COMPOUNDS

The present invention provides a compound of formula (I), (II), (III) and (IV) as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.